This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Lu Shan, Ph.D.
Senior Director, Antibody Discovery and Protein Engineering at Alector


Dr. Lu Shan is Sr. Director and Head of Antibody Discovery and Protein Engineering at Alector Therapeutics. She has 15 years of experience in drug discovery and development, small molecules and bispecific/multispecific antibody and protein therapeutics, across oncology, inflammation, metabolic and CNS diseases. She has had multiple high-impact publications including a body of work on the engineering of monovalent Fc platform and applications in drug discovery, publications in Science and PNAS on the mechanisms for Celiac disease and enzyme therapeutics. At Alector she has led the antibody and protein therapeutic development for multiple novel strategies to tackle neurodegeneration including the blood-brain barrier technology.

Agenda Sessions

  • Neuroimmune Interactions: From Basic Mechanisms to Novel CNS Therapeutics